Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Gastric Cancer × Paclitaxel × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 55 Breast Neoplasms 43 Ovarian Neoplasms 26 Triple Negative Breast Neoplasms 21 Endometrial Neoplasms 20 Lung Neoplasms 19 Fallopian Tube Neoplasms 16 Neoplasm Metastasis 15 Squamous Cell Carcinoma of Head and Neck 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Neoplasms 10 Carcinoma 8 Stomach Neoplasms 7 Head and Neck Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 7 Colorectal Neoplasms 7 Uterine Cervical Neoplasms 6 Carcinoma, Squamous Cell 6 Urinary Bladder Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Small Cell Lung Carcinoma 4 Oropharyngeal Neoplasms 4 Mouth Neoplasms 4 Laryngeal Neoplasms 4 Inflammatory Breast Neoplasms 4 Adenocarcinoma Of Esophagus 4 Prostatic Neoplasms 3 Hypopharyngeal Neoplasms 3 Hemangiosarcoma 3

Interventions

Trastuzumab 2 Oxaliplatin 2 Fluorouracil 2 Cisplatin 2 Capecitabine 2 trastuzumab deruxtecan 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡